Abstract
The number of procedures requiring anesthetic administration continues to
climb with the growing and aging population in many regions of the world. The
population of the world plays an important role in the growing incidence and
prevalence of disease and will reflect positively on growth for anesthesia
drugs. This Kalorama Information report - Anesthesia Drugs: Worldwide Markets
- focuses on three primary segments of anesthesia:
- General Anesthesia (Inhalation, Parenteral and Rectal)
- Local Anesthesia (Parenteral
- Adjunctive Therapies in Anesthesia
The report covers both currently marketed and late stage development
anesthesia drugs in detail. Revenues for each segment were generated using
dollar and unit sales for each product.
The report includes statistical information for surgical procedures, incidence
of conditions requiring surgery, and other relevant information. Statistical
information is presented as a worldwide overview, with special emphasis on the
U.S. The market segments provide an overview, description of products on the
market, description of products in development, market estimates and
forecasts, and competitive analysis of leading providers. The report also
includes current issues and trends affecting the industry.
The issues and trends addressed in the anesthesia drug market include:
- Regulation of Anesthesia Drugs
- Dentistry and Anesthesia
- Anesthesia and Pediatric Applications
- Anesthesia and Benefits to Depressed Patients
- Anesthesia and Sleep
- Gender Differences in Anesthesia Reaction
- Trends in Conscious Sedation
The information for this report was gathered using both primary and
secondary research including comprehensive research of secondary sources
such as company literature, databases, investment reports, and medical and
business journals. Telephone interviews and email correspondence were the
primary method of gathering information. For the purpose of this study
Kalorama Information conducted interviews with more than 50 key industry
officials, consultants, health care providers, and government personnel.
These sources were the primary basis in gathering information specifically
relating to revenue and market share data presented in this report. Specific
interviews with pharmaceutical company representatives included marketing
directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers' level. The
base year for data was 2006. Historical data is provided for the years
2004 and 2005, with forecast data provided for 2007 through 2011. Compound
annual growth rates (CAGRs) are provided for the 2004-2006, 2006-2011 and
2004-2011 periods for each industry segment covered. Competitive
analysis is provided for the year 2006 with a projected competitive
analysis for 2011.
The forecasted market analysis for 2007-2011 is based on probability of
approval and sales of products in late stage development, product marketing,
and demographic trends.
| 
View Cart
